Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study

M.I.H. Al-Jazairi, B.O. Nguyen, R.R. De With, M.D. Smit, B. Weijs, A.H. Hobbelt, M. Alings, J.G.P. Tijssen, B. Geelhoed, H.L. Hillege, R.G. Tieleman, D.J. Van Veldhuisen, H.J.G.M. Crijns, I.C. Van Gelder*, Y. Blaauw, M. Rienstra, RACE 3 Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)1359-1368
Number of pages10
JournalEP Europace
Volume23
Issue number9
DOIs
Publication statusPublished - 1 Sep 2021

Keywords

  • Atrial fibrillation
  • Early persistent atrial fibrillation
  • Antiarrhythmic drugs
  • Rhythm control
  • Heart failure
  • SINUS RHYTHM
  • AMIODARONE
  • MAINTENANCE
  • CARDIOVERSION
  • PREVENTION
  • EFFICACY
  • SOTALOL
  • SAFETY
  • AFFIRM
  • TERM

Cite this